STUDY OF DEPENDENCE OF RESPONSE TO THERAPY IN MULTIPLE MYELOMA ON PATHOLOGICAL PARAPROTEIN CLASS
Clinical data on the development of response to polychemotherapy in 26 multiple myeloma patients were analyzed. The dependence of response rate and adverse toxic reactions on the class of secreted pathological paraprotein and patients’ gender were studied. We found differences in achieving clinical response to polychemotherapy of other combination in dependence on the class of pathological paraprotein and gender of patients. The rate of toxic reactions in patients with multiple myeloma was commensurable with the used polychemotherapy regimen.